References
- Spangler D L., Dalof D D., Bloom F L., Whitting H J. Theophylline bioavailability following oral administration of six sustained-release preparations. Ann Allerg 1978; 40: 6
- Weinberger M, Hendeles L, Bighley L. The relation of product formulation to absorption of oral theophylline. New Engl J Med 1978; 299: 852
- Adams R F., Vandermark F L., Schmidt G H. More sensitive high pressure liquid chromatographic determinations of theophylline in serum. Clin Chem 1976; 22: 1903
- Hewlett-Packard Statistics Pac I Manual. NE Circle Boulevard, Corvallis, OR, 97330. Hewlett-Packard, 1000
- Gibaldi M, Perrier D. Pharmacokinetics. Marcel Dekker, Inc., New York 1975; Volume I: 293–296
- Wagner J G. Fundamentals of Clinical Pharmacokinetics, 1st ed, I L Hamilton. Drug Intelligence Publications, Inc. 1975; 174–176
- , Statistical Package of Social Sciences (SPSS), OS/360, Version M, Release 9.0 Documentation: SPSS Pocket Guide (SPSS, Inc, Suite 3300, 444 North Michigan Avenue, Chicago, IL 60611).
- Meyer M C., Straughn A B., Lieberman P. A multiple-dose study of sustained-release theophylline and aminophylline. Chest 1980; 78: 300
- Lesko L J., Canada A T., Eastwood G L., Clemente D R. The relative bioavailability of a controlled-release theophylline formulation after multiple doses. Immunol Allergy Pract 1981; III: 15
- Kann J, Levitt M J., Marquis N R. The comparative bioavailability of a new sustained-release theophylline preparation, Quibron®—T/SR, vs. Theo-Dur and Slo-Phyllin Gyrocaps. Curr Ther Res 1981; 30: 867
- Barrett W E., Hanigan J J., Snyder D L. The bioavailability of theophylline sustained-release tablets. Curr Ther Res 1981; 30: 335